Ostelin | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Ostelin
Health Canada Patents

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Ostelin

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

17 API Suppliers, 10 USDMF, 1 JDMF, 1 NDC API, 7 Listed Suppliers, $ API Reference Price

17 API Suppliers
10 USDMF
1 JDMF
1 NDC API
7 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

131 Drugs in Development

131 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

79 FDF Dossiers, 25 FDA Orange Book, 8 Europe, 4 Canada, 25 South Africa, 17 Listed Dossiers

79 FDF Dossiers
25 FDA Orange Book
8 Europe
4 Canada
25 South Africa
17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL, INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL, CAPSULE;ORAL - 50,000 IU, INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL
INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL
CAPSULE;ORAL - 50,000 IU
INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 14 SPI Pharma, 7 DKSH, 1 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 Kirsch Pharma, 4 ACG Worldwide, 5 Actylis, 10 BASF, 1 CD Formulation, 2 Finar, 6 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 1 Kerry, 3 Lonza Capsugel, 2 Microlex e.U, 1 Nanjing Bold Chemical, 3 Pluviaendo, 1 Qualicaps, 5 Roquette, 9 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 Valens Pharmachem

2 EUROAPI
1 Rochem International Inc
14 SPI Pharma
7 DKSH
1 Gangwal Healthcare
6 Nanjing Well Pharmaceutical
1 Pfanstiehl
4 Kirsch Pharma
4 ACG Worldwide
5 Actylis
10 BASF
1 CD Formulation
2 Finar
6 Gangwal Chemicals
1 Ingredion Pharma Solutions
1 Kerry
3 Lonza Capsugel
2 Microlex e.U
1 Nanjing Bold Chemical
3 Pluviaendo
1 Qualicaps
5 Roquette
9 Seppic
1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
1 Sigachi Industries
1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

23 Parenteral, 22 Fillers, Diluents & Binders, 20 Solubilizers, 14 Taste Masking, 14 Topical, 13 Direct Compression, 12 Chewable & Orodispersible Aids, 12 Thickeners and Stabilizers, 8 Empty Capsules, 8 Coating Systems & Additives, 7 Surfactant & Foaming Agents, 7 Disintegrants & Superdisintegrants, 7 Film Formers & Plasticizers, 6 Granulation, 6 Emulsifying Agents, 4 Co-Processed Excipients, 2 Coloring Agents, 2 Rheology Modifiers, 2 Lubricants & Glidants, 1 API Stability Enhancers, 1 Controlled & Modified Release

23 Parenteral
22 Fillers, Diluents & Binders
20 Solubilizers
14 Taste Masking
14 Topical
13 Direct Compression
12 Chewable & Orodispersible Aids
12 Thickeners and Stabilizers
8 Empty Capsules
8 Coating Systems & Additives
7 Surfactant & Foaming Agents
7 Disintegrants & Superdisintegrants
7 Film Formers & Plasticizers
6 Granulation
6 Emulsifying Agents
4 Co-Processed Excipients
2 Coloring Agents
2 Rheology Modifiers
2 Lubricants & Glidants
1 API Stability Enhancers
1 Controlled & Modified Release

DIGITAL CONTENT

6 News #PharmaBuzz

6 News #PharmaBuzz

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 9 Regulatory FDF Prices

8 US Medicaid Prescriptions
9 Regulatory FDF Prices

MARKET PLACE

18 APIs, 3 FDF Dossiers

18 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 JP, 3 Others

1 JP
3 Others

ANALYTICAL

1 Analytical Methods

1 Analytical Methods

$ API Ref.Price (USD/KG) : 779 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 2Gowling WLG (Canada) LLP

filter Patent Reset all filters

2 All

01 12294595

02 12399976

filter Product Reset all filters

2 All

01 2Risedronate Sodium | Calcium | Vitamin D

filter Dosage Reset all filters

2 All

01 2Kit (Tablet/Granules)

filter Exp Date Reset all filters

2 All

01 12018-07-17

02 12021-02-01

Product Main Page

01

Gowling WLG (Canada) LLP

Peptide Process CMC

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-07-17

Date Granted : 2001-08-21

Risedronate Sodium, Calcium, Vitamin D

Brand Name : ACTONEL SACHET KIT

Patent Number : 2294595

Filing Date : 1998-07-17

Strength per Unit : 35mg risedronate / tablet, 1000mg calcium & 880 IU

Dosage Form : Kit (Tablet/Granules)

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-07-17

Date Granted : 2001-08-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling WLG (Canada) LLP

Peptide Process CMC

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-02-01

Date Granted : 2007-03-27

Risedronate Sodium, Calcium, Vitamin D

Brand Name : ACTONEL SACHET KIT

Patent Number : 2399976

Filing Date : 2001-02-01

Strength per Unit : 35mg risedronate / tablet, 1000mg calcium & 880 IU

Dosage Form : Kit (Tablet/Granules)

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-02-01

Date Granted : 2007-03-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!